Completed PHASE1 INTERVENTIONAL 2-arm NCT02522325

Reinforcing Effects of Cocaine During Phendimetrazine Maintenance (BED IN 31)

Behavioral Effects of Drugs (Inpatient): 31 (Cocaine and Phendimetrazine)

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Cocaine Phendimetrazine Placebo

Updated 9 times since 2017 Last updated: Jun 10, 2019 Started: Aug 31, 2015 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Cocaine Use Disorder and is currently completed. National Institute on Drug Abuse (NIDA) leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Aug 2019 — Jan 2021 [monthly]

Completed PHASE1
Feb 2019 — Aug 2019 [monthly]

Completed PHASE1

Status: Recruiting → Completed

▶ Show 4 earlier versions

Jul 2018 — Feb 2019 [monthly]

Recruiting PHASE1
Jun 2018 — Jul 2018 [monthly]

Recruiting PHASE1
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE1

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
William Stoops

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lexington, United States